Sunday, June 21, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 451 of 1,261

  1. US 10517894

    Restimulation of cryopreserved tumor infiltrating lymphocytes

    Iovance Biotherapeutics, Inc. · Granted Dec 31, 2019 · Expires Dec 26, 2039

    granted

  2. US 10518074

    Compositions comprising nanostructures for cell, tissue and artificial organ growth, and methods for making and using same

    The Regents of the University of California · Granted Dec 31, 2019 · Expires Dec 26, 2039

    granted

  3. US 10517917

    Compositions and methods for preventing or treating pulmonary hypertension

    The Regents of the University of Colorado, a Body Corporate · Granted Dec 31, 2019 · Expires Dec 26, 2039

    granted

  4. US 10517908

    Therapeutic bacteriophage compositions

    Armata Pharmaceuticals, Inc. · Granted Dec 31, 2019 · Expires Dec 26, 2039

    granted

  5. US 10517920

    Antibacterial peptide and method of treatment using the antibacterial peptide

    UNITED ARAB EMIRATES UNIVERSITY · Granted Dec 31, 2019 · Expires Dec 26, 2039

    granted

  6. US 10519191

    Bile acid analogs as FXR/TGR5 agonists and methods of use thereof

    Enanta Pharmaceuticals, Inc. · Granted Dec 31, 2019 · Expires Dec 26, 2039

    granted

  7. US 10520517

    Disease severity index for assessment of chronic liver disease

    The Regents of the University of Colorado, a Body Corporate · Granted Dec 31, 2019 · Expires Dec 26, 2039

    granted

  8. US 10520499

    Methods of diagnosing and treating autism

    The Regents of the University of California · Granted Dec 31, 2019 · Expires Dec 26, 2039

    granted

  9. US 10519247

    Targeting HER2 and HER3 with bispecific antibodies in cancerous cells

    The Board of Regents of the University of Texas System · Granted Dec 31, 2019 · Expires Dec 26, 2039

    granted

  10. US 10519240

    Anti-FGFR1c antibody-FGF21 fusion proteins

    REGENERON PHARMACEUTICALS, INC. · Granted Dec 31, 2019 · Expires Dec 26, 2039

    granted

  11. US 10519447

    Therapeutic UNA oligomers and uses thereof

    ARCTURUS THERAPEUTICS, INC. · Granted Dec 31, 2019 · Expires Dec 26, 2039

    granted

  12. US 10519423

    High efficiency reprogramming of fibroblasts into cardiomyocytes

    The Regents of the University of Colorado, a Body Corporate · Granted Dec 31, 2019 · Expires Dec 26, 2039

    granted

  13. US 10519224

    Treating headache comprising administering an antibody to calcitonin gene-related peptide

    TEVA PHARMACEUTICALS INTERNATIONAL GMBH · Granted Dec 31, 2019 · Expires Dec 26, 2039

    granted

  14. US 10519186

    Nucleotide hemi-sulfate salt for the treatment of hepatitis C virus

    Atea Pharmaceuticals, Inc. · Granted Dec 31, 2019 · Expires Dec 26, 2039

    granted

  15. US 10519175

    Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use

    COMPASS Pathways Limited · Granted Dec 31, 2019 · Expires Dec 26, 2039

    granted

  16. US 10519222

    Broadly neutralizing monoclonal antibodies against HIV-1 V1V2 Env region

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 31, 2019 · Expires Dec 26, 2039

    granted

  17. US 10519205

    Compositions and methods for use of anion channel rhodopsins

    The Board of Regents of the University of Texas System · Granted Dec 31, 2019 · Expires Dec 26, 2039

    granted

  18. US 10519188

    Cyclic di-nucleotide compounds and methods of use

    The Board of Regents of the University of Texas System · Granted Dec 31, 2019 · Expires Dec 26, 2039

    granted

  19. US 10519110

    Heterocyclic compound

    Takeda Pharmaceutical Company Limited · Granted Dec 31, 2019 · Expires Dec 26, 2039

    granted

  20. US 10519133

    Vinyl compounds as FGFR and VEGFR inhibitors

    Medshine Discovery Inc. · Granted Dec 31, 2019 · Expires Dec 26, 2039

    granted

  21. US 10519139

    Polymorphs of Selinexor

    Karyopharm Therapeutics Inc. · Granted Dec 31, 2019 · Expires Dec 26, 2039

    granted

  22. US 10518002

    Intraocular drug delivery and filter device and methods of using same

    The Regents of the University of Colorado, a Body Corporate · Granted Dec 31, 2019 · Expires Dec 26, 2039

    granted

  23. US 10517953

    Modulators of PCSK9 expression

    Ionis Pharmaceuticals, Inc. · Granted Dec 31, 2019 · Expires Dec 26, 2039

    granted

  24. US 10519138

    Modulators of SOCE, compositions, and uses thereof

    UNIVERSITA DEGLI STUDI DEL PIEMONTE ORIENTALE · Granted Dec 31, 2019 · Expires Dec 26, 2039

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.